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Fourier transform infrared spectroscopypioid neuropeptides, function as ligands to the opioid kappa receptors and also
induce non-opioid effects in neurons, probably related to direct membrane interactions. We have
characterized the structure transitions of dynorphins (big dynorphin, dynorphin A and dynorphin B)
induced by the detergent sodium dodecyl sulfate (SDS). In SDS titrations monitored by circular dichroism, we
observed secondary structure conversions of the peptides from random coil to α-helix with a highly
aggregated intermediate. As determined by Fourier transform infrared spectroscopy, this intermediate
exhibited β-sheet structure for dynorphin B and big dynorphin. In contrast, aggregated dynorphin A was α-
helical without considerable β-sheet content. Hydrophobicity analysis indicates that the YGGFLRR motif
present in all dynorphins is prone to be inserted in the membrane. Comparing big dynorphin with dynorphin
A and dynorphin B, we suggest that the potent neurotoxicity of big dynorphin could be related to the
combination of amino acid sequences and secondary structure propensities of dynorphin A and dynorphin B,
which may generate a synergistic effect for big dynorphin membrane perturbing properties. The induced
aggregated α-helix of dynorphin A is also correlated with membrane perturbations, whereas the β-sheet of
dynorphin B does not correlate with membrane perturbations.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionDynorphin A (Dyn A), dynorphin B (Dyn B) and big dynorphin (Big
Dyn) are endogenous opioid peptides derived from prodynorphin. Big
Dyn consists of Dyn A for its N-terminus and Dyn B for its C-terminus
(Table 1). Dynorphins are synthesized in the striatum, amygdala,
hippocampus and other brain structures and also in the spinal cord
[1–8]. Dynorphin neuropeptides have a preferential afﬁnity for
κ-opioid receptors [9,10]. They play a role in pain processing, stress
response, motor control, memory acquisition and in reward response
induced by intake of addictive substances [11–14]. Besides opioid
receptor interactions, dynorphins have a non-opioid physiological
activity. Non-opioid activities of dynorphins can result in neurode-
generation and neuronal death. These activities relate to pathophy-
siological processes such as chronic neuropathic pain as well as spinal
cord and brain injury [15–21]. Non-opioid dynorphin actions can be
blocked by antagonists of theα-amino-3-hydroxy-5-methylisoxazole-
4-propionate/kainate (AMPA) glutamate receptors or the N-methyl-D-
aspartate (NMDA) glutamate receptor [22,23].
Dynorphins share common properties with cell penetrating
peptides (CPP) [24]: a high content of hydrophobic and basic amino
acid residues and the ability for Big Dyn and Dyn A to translocatem@dbb.su.se
ll rights reserved.across the cell plasma membrane into cells. Dyn A, and to an even
larger extent Big Dyn, but not Dyn B, induce leakage of the ﬂuorescent
dye calcein enclosed in large unilamellar phospholipid vesicles [25].
Similarly, Dyn A and particularly Big Dyn, but not Dyn B, cause inﬂuxof
calcium ions into large unilamellar vesicles with partially charged
headgroups [26]. The non-opioid activities of dynorphins could be
related to the direct membrane interactions of the peptides, which
may promote cellular entry and signalling inside the cell [24].
However, the physiological roles of the three neuropeptides and
their non-opioid activities seem to vary considerably despite the
sequence similarities [15,16].
Determination of conformations and structures of dynorphin
neuropeptides in the membrane environment is an essential step to
understand the action of the peptide to the specialized receptors. It
has been suggested that interaction with the membrane of the
target cell may induce a conformation and orientation of the
neuropeptide which will be recognized by the receptor [27]. Circular
dichroism (CD) and nuclear magnetic resonance (NMR) studies of
dynorphin peptides in the presence of small unilamellar vesicles
(with partly negatively charged phospholipid headgroups) and
bicelles have shown relatively weak secondary structure induction
[24,27,28]. Although the ﬁrst seven residues of Dyn A and Dyn B are
identical, their interactions with phospholipid membranes are
different [28].
In this study we used CD and Fourier transform infrared (FTIR)
spectroscopy to investigate the structure change in the dynorphin
Fig. 1. Residual hydrophobicity plot. Using the peptide partition from water to bilayer,
the segments better accommodated in the membrane were predicted. These are
indicated by black bars and more favorable energies. The segments prone to remain in
the interface are indicated by grey bars and less favorable energies.
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The dynorphin neuropeptides are highly positively charged. The SDS
detergent has negatively charged headgroups. We therefore expected
a rather strong interaction between the two types of molecules,
involving both electrostatic and hydrophobic interactions, promoting
stronger secondary structure changes than what was observed in
phospholipid vesicles and/or bicelles. We ﬁnd that at low SDS/peptide
ratios, the three peptides undergo aggregation and different second-
ary structure transitions, which may be related to their different
physiological roles.
2. Materials and methods
2.1. Materials
Dyn A, Big Dyn and Dyn B (Table 1) were produced by Neosystem
Laboratoire, Strasbourg. The peptides studied here were not modiﬁed
at the N- and C-termini. In vivo it is known that both non-modiﬁed
and C-terminally amidated forms of the peptide are found. SDS was
purchased from ICN Biomedicals Inc.
2.2. Determination of peptide concentrations
The concentration of peptides in aqueous stock solutions was
determined spectrophotometrically at λ=280 nm on a CARY 4 spectro-
photometer. A molar absorptivity at 280 nm of 5690 M−1 cm−1 for one
Trp and 1280 M−1 cm−1 for one Tyr residue was applied in the
calculations [29].
2.3. Preparation of SDS solution
The 200 mM SDS solution was prepared in 10 mM sodium
phosphate buffer pH 7.3, or 10 mM Tris–HCl buffer pH 7.3.
2.4. Hydrophobicity analysis
Total hydrophobicity and total hydrophobic moment shown in
Table 1 were calculated by the MPEx tool, available at StephenWhite's
lab (http://blanco.biomol.uci.edu/mpex/). The water-to-bilayer parti-
tioning residual hydrophobicity plot and transmembrane segment
prediction for Big Dyn were calculated using the same tool applying a
window size of 5 amino acids (see Fig. 1).
2.5. Circular dichroism spectroscopy
CD spectra were recorded from 190 to 250 nm, with a 0.2 nm
step resolution and 100 nm min−1 scanning speed on a Jasco J-720
CD spectropolarimeter equipped with a PTC-343 temperature
controller. The spectra were collected and averaged over 20 scans.
All experiments were performed at 20 °C, using quartz cells of
1.0 mm optical path length. Background signals were subtracted
from the CD spectra of the peptides. Peptide concentrations were
40 μM. Detergent containing samples had various concentrations of
SDS, ranging from 150 μM to 15 mM. The same peptide sample was
used for all measurements with gradually increasing SDS concen-
trations. A control experiment without peptide was performed inTable 1
Amino acid sequences analysis
Peptide Sequence Charge at pH 7.
Dyn A YGGFLRRIRPKLKWDNQ +4
Dyn B YGGFLRRQFKVVT +3
Big Dyn YGGFLRRIRPKLKWDNQKRYGGFLRRQFKVVT +9
The sequences have non-modiﬁed N- and C-termini. The common motif in dynorphins, YGG
a Values obtained from the totalizer tool included in the MPEx tool (details in the Materiorder to subtract the buffer/detergent contribution from the peptide
at each SDS titration step. Contributions of spectral components
from different secondary structures were estimated by computer
ﬁttings of the CD spectra with the JFIT program (written by
Bernhard Rupp, 1997) [30]. For short, ﬂexible peptides, these
estimations should not be taken as exact evaluations of secondary
structure contribution, but rather as reﬂecting relative changes in
secondary structure under varying conditions. The size of the
aggregates was veriﬁed by a light scattering analyzer (Zetasizer
Nano ZS, Malvern Instruments, Malvern, UK).
2.6. FTIR spectroscopy
To assure the removal of triﬂuoroacetic acid (TFA) from the
peptides, the peptide was dissolved in 0.1% deuterium chloride/D2O
solution during 1 h at a concentration of 1 mg/ml. The sample was
frozen in liquid N2 and lyophilized to dryness and then dissolved in
10 mM HEPES/D2O at pH 7.5, in the absence or presence of SDS (0,
3.75, 7.5 and 150 mM SDS dissolved in D2O) giving a peptide
concentration of 1 mM. This solution was placed in dismountable
BaF2 cuvette with 30 μm optical path. 1000 scans at 4 cm−1
resolution were acquired with a Bruker IFS/66 spectrometer at
20 °C. 2 experiments of 1000 scans each were averaged. Samples
without peptide were also prepared to perform buffer subtraction,
both in the absence and presence of SDS (concentrations of 7.5 and
150 mM). The spectra were corrected by subtraction of a linear
baseline and the second derivative minima were used to infer band
positions. Bands at the determined positions were ﬁtted to the
absorption spectra using the procedure described in Lórenz-Fonfría
et al. [31,32].0 Interfacial hydrophobicity (kcal/mol)a Hydrophobic momenta
1.49 3.12
−0.54 3.69
3.02 2.41
FLRR, is underlined.
als and methods section) under a water-to-bilayer partitioning.
Table 2.1
Secondary structure estimation of dynorphins: CD secondary structure analysis %
secondary structure components
Peptide Secondary structure 0 mM SDS 15 mM SDS SUVsa Bicellesb TFE 99%c
Big Dyn Random coil 77 47 63 N.A.d N.A.
α-helix 23 53 37 N.A. N.A.
Dyn A Random coil 76 45 68 60 35
α-helix 21 55 32 40 65
β-sheet 3 – – – –
Dyn B Random coil 79 40 70 63 20
α-helix 21 60 30 37 80
a Measurements were performed in 10 mM phosphate buffer, pH 7.0,with 40 μM of
peptides in presence of small unilamellar vesicles (SUVs) composed of 1 mM
phospholipids, mixed as POPC/POPG (70/30), at 25 °C [24].
b Measurements were performed in 50 mM phosphate buffer, pH 5.6,with 100 μM of
peptides in presence of bicelles composed of 250 mM phospholipids and detergent,
mixed as DHPC/DMPC/DMPG (77/16/7), at 37 °C [28].
c Measurements were performed in TFE 99%, with 100 μM of peptides, at 37 °C [28].
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3.1. Hydrophobicity analysis
White and Wimley determined a whole-residue interfacial hydro-
phobicity scale relating the free energy changes to the partitioning
from water to the membrane interface of unfolded peptide chains
[33,34]. This scale has been used to determine thermodynamics of
membrane protein folding [35], but also as a theoretical tool to predict
transmembrane segments [36]. In our case, the calculated propensity
of the different segments to be inserted in the membrane or to remain
in the water–bilayer interface was analyzed by the MPEx tool. Using
this tool, the sequences YGGFLRRI and RYGGFLRR of Big Dyn were
estimated to be transmembrane segments (see Fig. 1). Both segments
include the YGGFLRR sequence shared by Dyn A and Dyn B. The
segments estimated to remain in the water–bilayer interface are alsoFig. 2. CD spectra of dynorphin peptides in 10mM sodium phosphate buffer pH 7.3 with
varying SDS concentrations: 0 mM SDS, (solid black line); 0.15 mM SDS, (black dotted
line); 0.30 mM SDS, (solid grey line); 0.70 mM SDS, (asterisk); 2 mM SDS, (black dashed
line); 15mM SDS (open circle). (A) 40 μMBig Dyn, (B) 40 μMDyn A and (C) 40 μMDyn B.
d Not available.shown in Fig. 1. From the hydrophobic analysis of the sequence, the
total hydrophobicmoment and the propensity to remain in thewater–
bilayer interface were also calculated (see Table 1). Dyn B showed the
highest hydrophobicity (3.69) and a ΔG=−0.54 kcal/mol which
indicates a higher propensity of partitioning into the bilayer interface,
whereas Dyn A and Big Dyn, showed both lower hydrophobicities
(3.12 and 2.41 respectively) and were less prone of partitioning into
the bilayer interface (ΔG=1.49 and 3.02 kcal/mol respectively).
3.2. CD spectroscopy
CD measurements were performed to give an overview of the
secondary structures of the dynorphin peptides induced by an SDS
environment. Spectra were recorded in 10 mM sodium phosphate
solution at pH 7.3 with an initial peptide concentration of 40 μM and
varying concentrations of SDS, 0.15–15 mM, ranging from about four
times the peptide concentration to above the CMC. The CMC of SDS is
8.1 mM inwater, but addition of salt lowers the CMC [37]. Although no
salt was added to the buffer in the present studies, the interactionwith
the peptide may cause the CMC to change. The peptide sample was
titrated with SDS and the total dilution of the sample at the end of an
experimental series was no more than 10%. The results are presented
in Fig. 2. Table 2.1 shows the quantitative evaluations of the data in
terms of secondary structure components.
Big Dyn dissolved in the buffer with no SDS adopts a major random
coil conformationwith about 20% α-helix (Fig. 2A). Increasing the SDS
concentration from 0.15 to 1 mM leads to aggregation of the peptide,
observable as a gradual loss of the CD signal of the peptide in this SDS
range. At 0.3 mM SDS, corresponding to an SDS/peptide ratio of 7.5,
the CD signal has practically disappeared. The solution appearedmilky
by visual inspection and dynamic light scattering experiments
showed that the particles were approximately 2 μm in size (data not
shown). Still below the CMC, at 2 mM SDS, the CD signal reappears
with induction of about 50% α-helical secondary structure similar to
the induction (37%) in the presence of small vesicles [24]. Beyond the
“classical” CMC, at 15mM SDS (SDS/peptide=375), the CD signal of the
peptide remained unchanged, indicating that there was no further
induction of secondary structure in the peptide.
The CD spectra of Dyn A and Dyn B also showed structural
transitions like Big Dyn, although with somewhat different require-
ments of SDS concentrations for the structure transitions. Both Dyn A
(Fig. 2B) and Dyn B (Fig. 2C) lost CD signals between 0.15 and 0.3 mM
SDS (SDS/peptide ratios of 3.75 and 7.5, respectively) and appeared
milky by visual inspection. Like for Big Dyn, the CD signals of the
peptides reappeared at higher SDS concentrations, with about 40%
induction of α-helical secondary structure for Dyn A and 55% for Dyn
B, visible already around 0.7 mM. These CD signals changed only
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(see Table 2.1).
3.3. FTIR spectroscopy
In order to study the aggregated state of the peptides, transmis-
sion FTIR was carried out on Big Dyn, Dyn A and Dyn B peptides. To
reach a good signal-to-noise ratio, the peptide concentration used
was 1 mM. To model the conditions where the signal was diminished
in the CD experiments, the detergent concentration was scaled to
match the SDS/peptide ratio (7.5 mM SDS for Big Dyn and Dyn A and
3.75 mM for Dyn B, respectively). An SDS concentration above the
CMC was also used (150 mM; SDS/peptide ratio=150). The absor-
bance spectra were curve-ﬁtted in the 1705 to 1575 cm−1 spectral
range with 6 component bands (5 component bands for intermediate
SDS concentrations for Dyn A and Dyn B) at spectral positions
determined by the minima in the second derivative spectrum. Fig. 3
illustrates the procedure by showing the spectra and the respective
curve ﬁtting for Big Dyn at different SDS concentrations, correspond-
ing to SDS/peptide ratios of 0, 7.5 and 150. The curve ﬁtting performs
a quantitative analysis of the FTIR spectra. For the assignment of the
component bands, the frequency limits used were the following:
1696–1659 cm−1 for turns, 1689–1671 cm−1 and 1640–1619 cm−1 for
β-sheet, 1659–1645 cm−1 for α-helix and 1649–1636 cm−1 for
random coil. This assignment follows the spectrum–structure
correlations by Byler and Susi [38] and Goormaghtigh et al. [39],
with the exception of the spectral region of random coil, which was
extended by 2 cm−1 on the low wavenumber side, in order to include
component bands that could be assigned to random coil from the CDFig. 3. FTIR spectra of big dynorphin. Spectra including the amide I′ region for 1 mM big
temperature. (A)–(C) The measured absorption spectrum is shown in grey, the ﬁtted comp
1585 cm−1); (B) 7.5 mM SDS (6 bands ﬁtted: 1675, 1662, 1649, 1633, 1607 and 1584 cm−1); (C
control of the ﬁt model. The second derivative of the original spectrum is shown as a thick gr
the addition of the component bands (black lines in panels A–C) which had been ﬁtted to the
(upper panel); 7.5 mM SDS (middle panel); 150 mM SDS (lower panel).data. Since the regions of absorption of different secondary structures
overlap, some bands could be assigned to two different secondary
structures. The results are summarized in Table 2.2. For the secondary
structure estimation, the bands at ∼1605 and ∼1585 were ignored
since they were absent when the spectrumwas recorded in H2O (data
not shown). This is in line with their previous assignment to Arg side
chains in Dyn A [40].
A comparison of the FTIR results obtained for the three peptides
reveals that there are signiﬁcant differences in the band composition
and area depending on the SDS concentration. Fig. 3A depicts the
amide I′ region for Big Dyn in the absence of SDS (aqueous solution)
with themaximumat 1645 cm−1 and side bands at 1608 and 1585 cm−1.
The amide I′ component bands at 1675, 1665, 1652, and 1639 cm−1, as
well as the Arg bands 1608 and 1585 cm−1 are also shown in Fig. 3A.
The amide I′ bands are assigned as listed in Table 2.2. The α-helix
content was determined to 28% in very good agreement with the CD
evaluation (23%). The band at 1639 cm−1 can be assigned to random
coil or α-helix from its band position. Because the CD spectrum
indicates predominantly random coil structure, the 1639 cm−1 band
was assigned to random coil.
Fig. 3B shows the spectrum of Big Dyn in the presence of 7.5 mM
SDS, corresponding to an SDS/peptide ratio of 7.5 (and close to the
CMC threshold). Themaximum in this case is at 1647 cm−1. The amide I′
component bands are found at 1675, 1662, 1649, and 1633 cm−1. The
1633 cm−1 band clearly indicates a considerable contribution (34%) of
β-sheet in the aggregated structure. The α-helix content could not be
precisely determined since the band at 1649 cm−1 can be assigned to
both random coil and α-helix. Therefore, the α-helix content is
between 0 and 26%.dynorphin at different SDS concentrations, in 10 mM HEPES buffer pH 7.5 at room
onent bands in black. (A) 0 mM SDS (6 bands ﬁtted: 1675, 1665, 1652, 1639, 1608 and
) 150 mM SDS (6 bands ﬁtted: 1681, 1668, 1653, 1638, 1605 and 1585 cm−1). (D) Quality
ey line. The overlaid black line is the second derivative of the spectrum calculated from
experimental absorption spectrum (thick grey line in panels A–C). Conditions: 0mM SDS
Table 2.2
Secondary structure estimation of dynorphins: FTIR secondary structure analysis
0 mM SDS 7.5mMSDS(BigDynandDynA) /3.75mMSDS(DynB) 150 mM SDS
Peak position % Area Peptide Structure Peak position % Area Peptide structure Peak position % Area Peptide structure
Big Dyn 1675 6 Turnsa/(β-sheet) 1675 19 Turnsc/(β-sheet) 1681 2 Turnsa/(β-sheet)
1665 14 Turns 1662 21 Turns 1668 14 Turns
1652 28 α-helix 1649 26 α-helix/r.c. 1653 53 α-helix
1639 51 r.c.b/(β-sheet) 1633 34 β-sheet 1638 31 r.cb./(β-sheet)
Dyn A 1670 24 Turns 1672 19 Turnse 1678 15 Turns/β-sheet
1657 32 α-helix 1655 42 α-helix 1668 20 Turns
1645 25 r.c.d/(α-helix) 1641 39 r.c. 1653 29 α-helix
1637 18 r.c.b/(β-sheet) – – – 1637 35 r.c./β-sheet
Dyn B 1680 14 Turns/(β-sheet)a 1671 8 β-sheet/(turns)f 1678 20 Turnsc/(β-sheet)
1670 19 Turns 1643 52 r.c. 1663 24 Turns
1659 31 α-helix 1623 40 β-sheet 1650 26 α-helix
1642 37 r.c. – – – 1636 31 r.c./β-sheet
The frequency limits used for secondary structure assignment were the following: 1696–1659 cm−1, turns; 1689–1671 cm−1 and 1640–1619 cm−1, β-sheet; 1659–1645 cm−1, α-helix;
1649–1636 cm−1, random coil (r.c.).
a Assignment to turns and β-sheet possible. Bands were assigned to turns because the CD data did not give evidence for β-sheet structure.
b Assignment to r.c structure and β-sheet possible. Bands were assigned to r.c. because CD did not detect β-sheet structure.
c Assigned predominantly to turns because the high wavenumber band (above 1671 cm−1) of β-sheets has only 10–20% of the band area of the lower wavenumber β-sheet band.
Thus, the β-sheet contribution to the band is maximum 6–7% of the amide I area.
d Assignment to r.c structure and α-helix possible. Bands were assigned to r.c. because CD showed predominantly r.c. structure.
e Assignment to turns andβ-sheet possible from thebandposition. Since themain infrared bandofβ-sheets in the 1640–1619 cm−1 rangewasnot detected, thebandwas assigned to turns.
f Assignment to turns and β-sheet possible from the band position. Since the high wavenumber band (above 1671 cm−1) of β-sheets has 10–20% of the band area of the lower
wavenumber β-sheet band most of the absorption can be assigned to β-sheets.
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SDS on the Big Dyn peptide. The amide I′ maximum is shifted in this
case to 1651 cm−1 into the spectral region of α-helix absorption. The
positions of the amide I′ component bands are 1681, 1668, 1653, and
1638 cm−1. The structure is predominantly α-helical, in excellent
agreementwith the CD data. The band at 1638 cm−1 can be assigned to
β-sheet or random coil. We assigned it to random coil according to the
CD data.
The quality of the ﬁtted model was assessed by an overlay of the
second derivatives of the original experimental absorbance spectrum
and of the spectrum calculated by the addition of the ﬁtted
component bands (see Fig. 3D). The comparison indicates that the
ﬁtted component bands agree well with the component bands of the
original spectra.
1 mM of Dyn A and Dyn B were analyzed by FTIR spectroscopy at 0,
3.75, 7.5, 9 and 15mM SDS. The curve ﬁtting results for Dyn A and Dyn
B are summarized in Table 2.2. In the absence of SDS, the peptides
contain ∼30% α-helix, as Big Dyn, in good agreement with the CDFig. 4. Amide I′ region for dynorphin A (black line) and dynorphin B (grey line) at an
intermediate SDS concentration (7.5 and 3.75 mM respectively). Both spectra have been
normalized for their maximum intensity. Dyn A shows an amide I′ band centered at
1646 cm−1. Dyn B shows a typical antiparallel β-sheet spectrum, with a sharpmain band
at 1623 cm−1 and a weaker band at 1671 cm−1.data. Bands of the Dyn A spectrum at 1645 and 1637 cm−1 that can be
assigned to random coil or either α-helix or β-sheet, respectively,
were assigned to random coil, since the CD data indicated predomi-
nantly random coil structure. Accordingly, both peptides have ∼40%
random coil structure.
The amide I′ region for Dyn A at 7.5 mM SDS and Dyn B at 3.75 mM
SDS is shown in Fig. 4. The solutions appeared milky by visual
inspection at the concentrations of 3.75 and 7.5 mM of SDS for both
peptides as was the case for Big Dyn at 7.5 mM SDS (the only
intermediate SDS concentration studied for Big Dyn). Dyn B showed a
typical spectrum of antiparallel β-sheet structure at 3.75 mM SDS,
whereas Dyn A did not show traces of β-sheet structure at any
intermediate SDS concentration (see Fig. 4 and Table 2.2). Instead, Dyn
A had ∼40% α-helix at 3.75, 7.5 and 9 mM SDS.
At high SDS concentration (see Tables 2.1 and 2.2), the component
band positions where different from those at intermediate SDS
concentrations indicating that the structure at 3.75 and 7.5 mM SDS
is different from that at 150 mM SDS for both peptides. The secondary
structure observed by FTIR spectroscopy (SDS/peptide=150) for both
Dyn A and B indicated less than 30% α-helix, which is half of the
amount determined by CD spectroscopy at 15 mM SDS and 40 μM
peptide. This might indicate that the state in the infrared samples
(SDS/peptide=150) is different from that in the CD samples (SDS/
peptide=375). Because CD is particularly sensitive to the quantiﬁca-
tion of the α-helix content, the CD data at SDS concentrations above
the CMC are most straightforwardly interpreted and will be
exclusively discussed in the following.
Fig. 5 shows the α-helix and β-sheet structure trends at different
SDS/peptide ratios for the three peptides, observed by CD and FTIR
spectroscopy. No peptide had β-sheet structure in the absence of
SDS. At intermediate concentrations β-sheet structure appeared for
Big Dyn and Dyn B, while Dyn A showed α-helix structure. At high
SDS concentrations α-helix is the predominant structure for all
peptides.
4. Discussion
The dynorphin neuropeptides bind to membrane-embedded
receptors. Besides their receptor-mediated activities they have non-
receptor-mediated effects on neurons, probably involving direct
Fig. 5. α-helix and β-sheet content for big dynorphin, dynorphin A and dynorphin B at
increasing SDS/peptide ratios. Data for SDS/peptide ratios of 0 and 375 were obtained
from the CDmeasurements, data for the SDS/peptide ratio of 7.5 from the FTIR data (see
Tables 2.1 and 2.2). For the latter conditions, the β-sheet contentwas evaluated from the
main β-sheet band at low wavenumber. The α-helix content of Big Dyn at the SDS/
peptide ratio of 7.5 could not be determined precisely (see Tables 2.1 and 2.2 and text);
error bars indicate the maximum and minimum probability of α-helical percentage.
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studies of membrane interactions and secondary structure changes
are important. We have chosen the detergent SDS for the present
studies, in order to enhance the weaker secondary structural changes
earlier observed by CD and NMR studies in the presence of
phospholipid vesicles and mixed micelles (bicelles) [24,28]. We have
now also applied FTIR spectroscopy to assess the secondary structure
of an aggregated intermediate structure that could not be studied by
CD. We observe that the CD and FTIR techniques complement and
strengthen each other.
We analyzed the water-to-bilayer partitioning of Big Dyn using the
experimental whole-residue interfacial hydrophobicity scale deter-
mined by White and Wimley. The highest propensity of membraneinsertion is shown by the Dyn A and Dyn B common sequence
(YGGFLRR).
The CD secondary structure analysis in the absence of SDS
indicates a high percentage of random coil structure and ∼20% α-
helix in all three peptides (Table 2.1). CD spectra of all three peptides at
SDS concentrations above the CMC showed a signiﬁcant increase of
the α-helical content. The CD spectra at high SDS concentrations are
similar to corresponding spectra in the presence of phospholipid
vesicles [24]. Table 2.1 also includes evaluations of secondary structure
components of the dynorphins in other membrane mimetic systems.
These include small phospholipid vesicles, mixed micelles (bicelles)
and TFE. For Big Dyn, the α-helical content ranges from 37% in small
unilamellar phospholipid vesicles to the 53% reached at 15 mM SDS.
For Dyn A andDyn B, themaximumα-helical content is reached in TFE
(65 and 80% respectively), followed by SDS (55 and 60% respectively),
bicelles (40 and 37% respectively) and phospholipid vesicles (32 and
30% respectively).
In addition, FTIR spectroscopy allowed us to analyze the
secondary structure composition of Big Dyn, Dyn A and Dyn B at
an intermediate SDS concentration (3.75 and 7.5 mM SDS for FTIR,
corresponding to 0.15 and 0.3 μM SDS for CD, to give the same
SDS/peptide ratios of 3.75 and 7.5 for both FTIR and CD
experiments, respectively), which led to peptide aggregation as
indicated by the milky appearance of the samples. The aggregated
species were not observable in the CD experiments, due to a
diminished CD signal, but were observed as 2 μm particles by DLS
in an experiment with Big Dyn at a SDS/peptide ratio of 7.5. The
observed aggregation reﬂects what could occur at a high
concentration of peptides in a negatively charged hydrophobic
environment. Due to the positive charge of the peptides and the
anionic headgroups of the detergent, the sum of electrostatic
effects and the peptide hydrophobicity induces aggregation, similar
to what has been reported for the chlorin p6 molecule [41]. Thus,
SDS is expected to be incorporated into the aggregates. The
solubilization of the aggregates at micellar SDS concentrations is
explained as an override of the electrostatic repulsion at sufﬁciently
high detergent concentrations [42].
However, the secondary structure of the aggregates observed by
FTIR appeared to be quite different for the three peptides. Dyn B and
Big Dyn contain a large portion of β-sheets, in contrast to Dyn A
which has considerable α-helix structure, but no β-sheet structure.
We suggest that α-helix and β-sheet appear in the N-terminus and
C-terminus of Big Dyn, respectively (corresponding to the sequences
of Dyn A and Dyn B, respectively, see Table 1). In line with this, the
β-sheet content of Big Dyn is less than that of Dyn B, and the α-
helix content is less than that of Dyn A. However, it is also clear that
the structure of the Big Dyn aggregates is not simply an addition of
the structures of aggregated Dyn A and Dyn B. This is evident from
shifts in the position of the component bands in the FTIR spectra.
For example, the β-sheet of Dyn B absorbs at 1623 cm−1, whereas
that of Big Dyn absorbs at 1633 cm−1.
Interestingly, β-sheet-rich aggregates induced by intermediate
concentrations of SDS have also been reported for the amyloid β
(Aβ) peptides involved in Alzheimer's disease [43–45]. For Aβ(1–40)
and Aβ(1–42), the authors have suggested that the aggregates may
mimic β-sheet-rich neurotoxic oligomeric aggregates of Aβ. The
results reported here for dynorphins indicate a neurotoxic role also
for α-helical aggregates. We suggest that the propensity of Dyn A to
form aggregates rich in α-helix at submicellar concentrations of SDS
may be associated with its neurotoxic effects [15,16,46]. The
aggregates rich in α-helix observed for Dyn A may be similar to
the aberrant α-helical coiled coils observed in the Alzheimer's
disease related tau protein [47,48]. Dyn B is associated with less
disruptive membrane interactions [25] and less neurotoxicity
[15,16,46] than Dyn A and this may be related to its propensity to
form β-sheet aggregates at submicellar SDS concentrations. Thus,
2586 L. Hugonin et al. / Biochimica et Biophysica Acta 1778 (2008) 2580–2587we speculate that the β-sheet aggregates may represent a less
membrane perturbing form of an aggregated neuropeptide than the
α-helical aggregates.
Big Dyn also shows stronger cytotoxic effects when compared to
Dyn B [46]. The N-terminal segment of Dyn A and Dyn A derived
fragments (YGGFLRR) has been shown to be inserted in micelles,
bicelles and lipid bilayers [28,49,50], but not the N-terminus of Dyn
B. The double representation of the YGGFLRR and the RYGGFLRR
segments in Big Dyn may play a relevant role in the neurotoxic
pathway of dynorphins. These positively charged segments could act
as strong anchors to partly negatively charged membranes, as has
been shown to occur with other aggregating proteins involved in
neuropathological processes, such as α-synuclein in Parkinson's
disease [51,52], or with cationic antimicrobial peptides [42]. This
could explain the stronger cytotoxic effect of Big Dyn compared to
the shorter peptides by generating a synergistic effect in the
membrane perturbing properties of Big Dyn [15,16,25,46].
4.1. Concluding remarks
To the best of our knowledge this is the ﬁrst evidence for
aggregation in dynorphin neuropeptides. The aggregates obtained in
this study were induced by submicellar concentrations of SDS, which
is not directly related to cell or model lipid bilayers, where most of the
neurotoxicity/leakage studies have been carried out. Nevertheless,
this detergent may mimic speciﬁc physiological conditions due to its
hydrophobicity, negative charge and its characteristic of being a
strong secondary structure inducer. The fact that under the same
detergent conditions (submicellar and close to micellar SDS concen-
trations), Dyn A and Dyn B yield aggregates with α-helix and β-sheet
structure, respectively (and a mixture of both structures for Big Dyn),
should be considered as a relevant hint on the neurotoxic roles of
these peptides.
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